Reclazepam
Clinical data
ATC code
  • none
Identifiers
  • 2-[7-chloro-5-(2-chlorophenyl)-2,3-dihydro-1,4-benzodiazepin-1-yl]-1,3-oxazol-4-one
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC18H13Cl2N3O2
Molar mass374.22 g·mol−1
3D model (JSmol)
  • Clc1ccccc1/C4=N/CCN(C\2=N\C(=O)CO/2)c3ccc(Cl)cc34
  • InChI=1S/C18H13Cl2N3O2/c19-11-5-6-15-13(9-11)17(12-3-1-2-4-14(12)20)21-7-8-23(15)18-22-16(24)10-25-18/h1-6,9H,7-8,10H2 checkY
  • Key:MQGIGGJUPITZSE-UHFFFAOYSA-N checkY
  (verify)

Reclazepam[1] is a drug which is a benzodiazepine derivative. It has sedative and anxiolytic effects similar to those produced by other benzodiazepine derivatives, and has a short duration of action.[2]

See also

References

  1. ^ US 4208327, Yonan PK, "5-Aryl-1-(2-oxazolin-2-yl)-1H-1,4-benzodiazepines and related compounds", issued 17 June 1980, assigned to GD Searle LLC. 
  2. ^ "Reclazepam". Pscyhotropics.dk. 20 January 1986. Retrieved 24 August 2009.((cite web)): CS1 maint: url-status (link)